cisplatin,pemetrexed
Showing 1 - 1 of 1
NSCLC Trial in Tianjin (biological, drug, radiation)
Recruiting
- Non-small Cell Lung Cancer
- Camrelizumab
- +5 more
-
Tianjin, ChinaLiu ningbo
May 7, 2021